Vitamin D deficiency and co-morbidities in COVID-19 patients – a fatal relationship?

Hans K. Biesalski

NFS Journal. 2020 Aug; 20: 10–21

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276229/

 

Why does COVID-19 disproportionately affect older people?

Amber L. Mueller, Maeve S. McNamara, David A. Sinclair

Aging (Albany NY) 2020 May 31; 12(10): 9959–9981

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288963/

 

Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade

Luca Perico, Ariela Benigni, Giuseppe Remuzzi

Nephron Clin Pract. 2020 Mar 23 : 1–9

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179544/

 

Follow-up studies in COVID recovdered patients – is it mandatory?

Vellingiri Balachandar, Iyer Mahalaxmi, Mohandevi Subramaniam et al

Sci Total Environ. 2020 Aug 10; 729: 13902

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184970/

 

After the COVID-19 pandemic: returning to normalcy or returning to a new normal?

Erik N. Zeegen, Adolph J. Yates, David S. Jevsevar

J Arthroplasty. 2020 Jul; 35(7): S37–S41.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195118/

 

Is antibody-dependent enhancement playinng a role in COVID-19 pathogenesis?

N Francesco

Swiss Med Wkly 2020, vol 150: w20249

https://smw.ch/article/doi/smw.2020.20249

 

D-dimer and mortality in COVID-19: a self-fulfillinng profhecy or a pathophysiological clue?

N Breakey, R Escher

Swiss Med Wkly 2020, vol 150: w20293

https://smw.ch/article/doi/smw.2020.20293

 

Hepatic consequences of COVID-19 infection. Lapping or biting?

Piero Portincasa, Marcin Krawczyk, Antonia Machill et al

Eur J Intern Med. 2020 Jun 1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262543/

 

Considerations for oral and maxillofacial surgeons in COVID-19 era: Can we sustain the solutions to keep our patients and healthcare personnel safe?

Radhika Chigurupati, Neeraj Panchal, Andrew M. Henry et al

J Oral Maxillofac Surg. 2020 May 24

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246053/

 

Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endotelial disease? A comprehensive evalutation of clinical and basic evidence

Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli,et al

J Clin Med. 2020 May; 9(5): 1417

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290769/

 

Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?

Carlo Torti, Maria Mazzitelli, Enrico Maria Trecarichi, Owachi Darius

BMC Infect Dis. 2020; 20: 412

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293889/

 

Should we stimulate or supress imune responses in COVID-19? Cytokine and anti-cytokine interventions

Yvan Jamilloux, Thomas Henry, Alexandre Belot, et al

Autoimmun Rev. 2020 Jul; 19(7): 102567

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196557/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: junho 2020